| Literature DB >> 27144405 |
Zhuyingjie Fu1,2, Yang Liu1,2, Chunhui Chen1,2, Yan Guo1,2, Ying Ma1,2, Yang Yang1,2, Fupin Hu1,2, Xiaogang Xu1,2, Minggui Wang1,2.
Abstract
To investigate the prevalence, location and genetic environments of fosfomycin-resistance (fos) genes in methicillin-resistant Staphylococcus aureus (MRSA) clinical strains, 67 fosfomycin-resistant MRSA strains were isolated from the blood and cerebrospinal fluid samples at a teaching hospital in Shanghai. The presence of fos genes in these clinical strains was detected by PCR and sequencing. The locations of fos genes were determined by Southern blotting and genetic environments were analyzed by primer walking sequencing. Multiple locus sequence typing (MLST) was used to characterize genetic diversity. Conjugation was performed to evaluate the transferability of fos genes. Among 67 fosfomycin-resistant MRSA strains, nine high level fosfomycin resistant strains (≥128 μg/ml) were fosB-positive. Three new subtypes of fosB, designated as fosB4, fosB5, and fosB6, were identified. fosB1, fosB4 or fosB6 genes were located on small plasmids (ca. 2.5 kb) and flanked by an analogous replication gene (rep). Differently, the fosB5 gene was surrounded by a shorter rep gene and two copies of a transposon gene (tnp) that shared high identity with the IS257-like transposon. Four MLST types were found among the nine fosB-positive strains. Transconjugants with the fosB genes were resistant to fosfomycin with MIC 64 or 128 μg/ml. In conclusion, different subtypes and genetic environment of fosB genes indicate that gene heterogeneity for fosfomycin resistance in MRSA isolates.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27144405 PMCID: PMC4856351 DOI: 10.1371/journal.pone.0154829
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of fosB-positive isolates and transconjugants.
| Strains | Fosfomycin MIC (μg/ml) | Source | Ward | Fosfomycin exposure | Plasmid size (kb) | MLST type | |
|---|---|---|---|---|---|---|---|
| SA0406 | >256 | Blood | Dermatology | Existent | 2.6 | ST5 | |
| SA0409 | >256 | Blood | Dermatology | Existent | 2.3 | ST5 | |
| SA0516 | >256 | Blood | Dermatology | Existent | 2.3 | ST5 | |
| SA0849 | >256 | Blood | Hematology | Nonexistent | 2.3 | ST5 | |
| SA1057 | >256 | Blood | Infection Department | Nonexistent | 2.6 | ST764 | |
| SA1159 | >256 | Blood | Geriatrics | Nonexistent | 2.6 | ST2590 | |
| SA1278 | >256 | Spiral fluid | Neurosurgery | Nonexistent | 2.9 | ST5 | |
| SA1280 | >256 | Spiral fluid | Neurosurgery | Existent | Unclear | ST5 | |
| SA0620 | 128 | Blood | Neurology | Existent | Unclear | ST239 | |
| Transconjugant0406 | 64 | NA | NA | NA | 2.6 | NA | |
| Transconjugant0409 | 64 | NA | NA | NA | 2.3 | NA | |
| Transconjugant0516 | 64 | NA | NA | NA | 2.3 | NA | |
| Transconjugant0849 | 64 | NA | NA | NA | 2.3 | NA | |
| Transconjugant1057 | 64 | NA | NA | NA | 2.6 | NA | |
| Transconjugant1159 | 64 | NA | NA | NA | 2.6 | NA | |
| Transconjugant1278 | 64 | NA | NA | NA | 2.9 | NA | |
| Transconjugant1280 | 128 | NA | NA | NA | Unclear | NA | |
| Transconjugant0620 | 128 | NA | NA | NA | Unclear | NA | |
| NA | 2 | NA | NA | NA | NA | NA |
*Exposure to fosfomycin within one month was defined as “Existent” history prior to the positive blood/CSF culture.
#Unclear = uncertainty about the location of fosB.
§NA = not applicable
Percent identity in nucleotide and deduced amino acid sequence for fosB subtypes.
| Nucleotide sequence | Deduced amino acid | |||||
|---|---|---|---|---|---|---|
| New subtype | ||||||
| 99.5% | 62.2% | 99.3% | 99.3% | 59.0% | 98.6% | |
| 99.8% | 62.2% | 99.5% | 99.3% | 59.0% | 98.6% | |
| 99.3% | 60.5% | 99.0% | 97.8% | 58.3% | 97.1% | |
Fig 1Comparison of the sequences of fosB genes.
Diversity of amino acids among fosB gene subtypes (A). Diversity of deduced amino acid sequences of fosB and genetic environment (B). Amino acid relationships of FosB4-6 with FosA1-4, FosB1-3, FosC1-2 and FosX (C). Adjacent sequences of fosB1-6: fosB1 (AP006717) in S. haemolyticus, fosB2 (NC_012581) from Bacillus anthracis, fosB3 (HQ219726) from E. faecium, fosB4 (KR870311) from S. aureus SA0406, fosB5 (KT032253) from S. aureus SA1280, and fosB6 (KR870314) from S. aureus SA1278. The residues differing from the consensus sequence are boxed in inverse color. Two IS257 elements (790 bp) are indicated as open boxes. Arrowheads within the IS257 elements represent terminal inverted repeats. rep* means a shorter rep gene in SA1280, with 38.5% nucleotide identity to those in S. haemolyticus (AP006717) and S. aureus (KR870311, KR870314) which had an high identity in rep. The unrooted dendrogram was generated by Clustal W (http://www.genome.jp/). Proteins not mentioned above(GenBank accession no.): FosA (AAA98399); FosA2 (ACC85616); FosA3 (BAJ10054); FosA4 (BAP18892.1); FosC (CAA83855); FosC2 (BAJ10053); FosX (YP_005926752).
Fig 2Southern hybridization analysis of fosB-positive MRSA isolates.
Lanes: 1, PCR product of fosB gene as the positive control; 2, S. aureus SA0849; 3, S. aureus SA0620; 4, S. aureus SA0516; 5, S.aureus SA0409; 6, S. aureusSA1280; 7, S. aureus SA1278; 8, S. aureus SA0406; 9, S. aureus SA1159; 10, S. aureus SA1057; 11, plasmid V517 derived from E. coli as the marker.